DexCom (DXCM) Competitors

Becton, Dickinson and Company (NYSE:BDX) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.

Do analysts rate BDX or DXCM?

Becton, Dickinson and Company currently has a consensus target price of $278.29, suggesting a potential upside of 21.47%. DexCom has a consensus target price of $99.82, suggesting a potential upside of 32.53%. Given DexCom's higher possible upside, analysts clearly believe DexCom is more favorable than Becton, Dickinson and Company.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
DexCom	0 Sell rating(s)	4 Hold rating(s)	13 Buy rating(s)	2 Strong Buy rating(s)	2.89

Which has more risk and volatility, BDX or DXCM?

Becton, Dickinson and Company has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.28, meaning that its stock price is 28% more volatile than the S&P 500.

Do insiders and institutionals have more ownership in BDX or DXCM?

87.0% of Becton, Dickinson and Company shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.4% of Becton, Dickinson and Company shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Does the media favor BDX or DXCM?

In the previous week, Becton, Dickinson and Company had 14 more articles in the media than DexCom. MarketBeat recorded 39 mentions for Becton, Dickinson and Company and 25 mentions for DexCom. DexCom's average media sentiment score of 1.33 beat Becton, Dickinson and Company's score of 1.30 indicating that DexCom is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	30 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	23 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is BDX or DXCM more profitable?

DexCom has a net margin of 14.29% compared to Becton, Dickinson and Company's net margin of 8.47%. DexCom's return on equity of 30.14% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	8.47%	15.74%	7.29%
DexCom	14.29%	30.14%	10.11%

Does the MarketBeat Community believe in BDX or DXCM?

DexCom received 379 more outperform votes than Becton, Dickinson and Company when rated by MarketBeat users. Likewise, 71.74% of users gave DexCom an outperform vote while only 62.41% of users gave Becton, Dickinson and Company an outperform vote.

Company	Underperform	Outperform
Becton, Dickinson and Company	Outperform Votes 601 62.41%	Underperform Votes 362 37.59%
DexCom	Outperform Votes 980 71.74%	Underperform Votes 386 28.26%

Which has better earnings and valuation, BDX or DXCM?

Becton, Dickinson and Company has higher revenue and earnings than DexCom. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$20.64B	3.19	$1.71B	$6.02	38.06
DexCom	$4.03B	7.30	$576.20M	$1.43	52.67

Summary

DexCom beats Becton, Dickinson and Company on 13 of the 19 factors compared between the two stocks.